MARTELLI, Maurizio
 Distribuzione geografica
Continente #
NA - Nord America 2.827
EU - Europa 1.600
AS - Asia 1.440
SA - Sud America 92
OC - Oceania 86
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.101
Nazione #
US - Stati Uniti d'America 2.689
CN - Cina 724
IT - Italia 561
JP - Giappone 240
DE - Germania 187
FR - Francia 173
GB - Regno Unito 154
CA - Canada 120
IN - India 92
AU - Australia 83
NL - Olanda 82
HK - Hong Kong 75
ES - Italia 60
TW - Taiwan 48
IE - Irlanda 43
CH - Svizzera 37
IR - Iran 35
GR - Grecia 34
RU - Federazione Russa 33
TH - Thailandia 31
DK - Danimarca 30
SE - Svezia 29
TR - Turchia 29
KR - Corea 27
BR - Brasile 25
SG - Singapore 24
CO - Colombia 23
PL - Polonia 23
SA - Arabia Saudita 22
UA - Ucraina 22
CZ - Repubblica Ceca 21
ZA - Sudafrica 18
BE - Belgio 17
PT - Portogallo 16
HU - Ungheria 15
IL - Israele 15
RO - Romania 15
ID - Indonesia 14
MX - Messico 13
MA - Marocco 12
AR - Argentina 11
LT - Lituania 11
PE - Perù 11
CL - Cile 10
EG - Egitto 9
FI - Finlandia 9
MY - Malesia 8
NO - Norvegia 8
PK - Pakistan 8
TN - Tunisia 8
VN - Vietnam 8
EC - Ecuador 7
IQ - Iraq 7
PS - Palestinian Territory 7
AT - Austria 6
HR - Croazia 5
PH - Filippine 5
DZ - Algeria 4
KH - Cambogia 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
LB - Libano 3
NZ - Nuova Zelanda 3
A1 - Anonimo 2
CU - Cuba 2
OM - Oman 2
PY - Paraguay 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
AL - Albania 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GH - Ghana 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
PA - Panama 1
RS - Serbia 1
UY - Uruguay 1
YE - Yemen 1
Totale 6.101
Città #
Ashburn 305
Houston 249
Fairfield 178
Rome 146
Santa Cruz 136
Woodbridge 134
Buffalo 131
Ann Arbor 128
Beijing 124
Seattle 91
Tokyo 64
Cambridge 54
Columbus 53
Milan 51
Shanghai 50
Wilmington 44
Tianjin 41
Nanjing 40
Taipei 40
Hangzhou 37
San Diego 36
Chicago 35
Dublin 35
Fuzhou 35
Amsterdam 33
New York 32
Las Vegas 29
Toronto 29
Los Angeles 27
Chengdu 25
Wuhan 24
Shenyang 23
Bengaluru 22
Central 22
Central District 22
Guangzhou 21
San Jose 21
Jinan 20
Des Moines 19
Rochester 19
Boardman 18
Changsha 18
Bologna 17
Paris 17
London 16
Ottawa 16
Phoenix 16
Berlin 15
Stockholm 15
Dearborn 14
Bogotá 13
Dallas 13
Duncan 13
Guiyang 13
Lake Forest 13
Odense 13
San Francisco 13
Seoul 13
Utrecht 13
Boston 12
Council Bluffs 12
Melbourne 12
Trieste 12
Athens 11
Budapest 11
Clearwater 11
Muizenberg 11
Sydney 11
Torino 11
Baltimore 10
Brisbane 10
Chennai 10
Lausanne 10
Leiden 10
Lima 10
Madrid 10
Zhengzhou 10
Atlanta 9
Jakarta 9
Nagoya 9
Tehran 9
The Dalles 9
Zurich 9
Catania 8
Fleming Island 8
Florence 8
Henderson 8
Kharagpur 8
Portland 8
Riva 8
Warsaw 8
Zvezda 8
Barcelona 7
Bethesda 7
Changchun 7
Havertown 7
Helsinki 7
Providence 7
Shenzhen 7
Suzhou 7
Totale 3.280
Nome #
Primary mediastinal large B-cell lymphoma, file e3835318-be68-15e8-e053-a505fe0a3de9 1.427
Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi, file e3835318-d366-15e8-e053-a505fe0a3de9 1.037
Primary mediastinal lymphoma: diagnosis and treatment options., file e3835318-afde-15e8-e053-a505fe0a3de9 656
Is now the time for molecular driven therapy for diffuse large B-cell lymphoma?, file e3835318-d6c1-15e8-e053-a505fe0a3de9 499
Comprehensive geriatric assessment is an essential tool to support treatment decisions in elderly patients with diffuse large B-cell lymphoma: A prospective multicenter evaluation in 173 patients by the Lymphoma Italian Foundation (FIL), file e3835318-855b-15e8-e053-a505fe0a3de9 483
The 68Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma), file e3835318-7e23-15e8-e053-a505fe0a3de9 281
Critical concepts, practice recommendations, and research perspectives of pixantrone therapy in non-Hodgkin lymphoma: a SIE, SIES, and GITMO consensus paper, file e3835318-c565-15e8-e053-a505fe0a3de9 243
Baseline PET features to predict prognosis in primary mediastinal B cell lymphoma: a comparative analysis of different methods for measuring baseline metabolic tumour volume., file e3835321-bf6f-15e8-e053-a505fe0a3de9 234
Rituximab and autologous stem-cell transplantation for high-risk diffuse large B-cell lymphoma - Authors' reply, file e3835318-0261-15e8-e053-a505fe0a3de9 151
Diffuse large B-cell lymphoma., file e3835312-3fb6-15e8-e053-a505fe0a3de9 147
Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up, file e3835318-bdca-15e8-e053-a505fe0a3de9 136
Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma, file e3835318-7c7d-15e8-e053-a505fe0a3de9 131
null, file e383532a-72ca-15e8-e053-a505fe0a3de9 124
Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Patients: A Retrospective Analysis of Eligibility Criteria for CAR-T Cell Therapy, file e3835327-0791-15e8-e053-a505fe0a3de9 94
COVID-19 in patients with hematologic disorders undergoing therapy: perspective of a large referral hematology center in Rome, file e3835328-7592-15e8-e053-a505fe0a3de9 87
In Reply to Adams and Kwee, file e3835318-7e1d-15e8-e053-a505fe0a3de9 86
Cytological diagnostic features of late breast implant seromas. From reactive to anaplastic large cell lymphoma, file e3835317-dbb0-15e8-e053-a505fe0a3de9 83
Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study, file e3835326-e5d3-15e8-e053-a505fe0a3de9 70
Reduced transmission of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) in patients with haematological malignancies hospitalized in an Italian hospital during the COVID-19 pandemic, file e383532d-934c-15e8-e053-a505fe0a3de9 65
Clinical recommendations for diagnosis and treatment according to current updated knowledge on BIA-ALCL, file 999a445c-5881-4183-af06-009237019020 36
High basal maximal standardized uptake value (Suvmax) in follicular lymphoma identifies patients with a low risk of long-term relapse, file e383532c-a95a-15e8-e053-a505fe0a3de9 21
Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized Study., file e3835312-3fb7-15e8-e053-a505fe0a3de9 18
Lymphadenopathies before and during the pandemic COVID-19: increasing incidence of metastases from solid tumors, file a22197bc-b205-4ebc-8c46-c227aa3317b0 16
The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma, file e3835318-a6bb-15e8-e053-a505fe0a3de9 14
Management of Relapsed/Refractory All with Inotuzumab During COVID-19. A Case Report, file 61281648-2c18-473a-aa8a-2e40962c9780 13
Efficacy of ibrutinib as salvage treatment in a secondary central nervous system lymphoma (SCNSL) progressed after chemorefractory Primary Mediastinal B Cell Lymphoma (PMBCL), file e383532f-1b71-15e8-e053-a505fe0a3de9 13
Long-term host immune modulation following tisagenlecleucel administration in patients with diffuse large b-cell lymphoma and b-lineage acute lymphoblastic leukemia, file 64433d44-d310-48ee-b694-799f96d423a3 12
Whole body MRI with diffusion weighted imaging versus 18F‑fuorodeoxyglucose‑PET/CT in the staging of lymphomas, file 6e924d4e-3c5d-4a71-b08a-990fabc419df 12
Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept. A case report and literature review, file e3835311-ae9b-15e8-e053-a505fe0a3de9 10
Bing-Neel syndrome coexisting with oligodendroglioma, file e383532f-04ce-15e8-e053-a505fe0a3de9 8
Surgery in primary gastric lymphoma: impact on clinical staging and long-term survival., file e3835311-e0e1-15e8-e053-a505fe0a3de9 7
Relapsed/Refractory Multiple Myeloma Patients. A Multicenter Retrospective Analysis of Eligibility Criteria for CAR-T Cell Therapy, file e383532e-36ae-15e8-e053-a505fe0a3de9 7
Efficacy of residual site radiation therapy (ISRT) in patients with primary mediastinal lymphoma with Deauville Score 4 following R-CHT: results of a retrospective mono institutional study, file 3f92368c-fa7a-4dbd-b0b8-5e288d43c1b7 5
Relapsed/refractory diffuse large B-cell lymphoma patients. A multicenter retrospective analysis of eligibility criteria for car-T cell therapy, file e3835328-bff2-15e8-e053-a505fe0a3de9 5
Corrigendum to "Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept: A case report and literature review" [Leuk. Res. 36 (2012) e199-e201], file e3835318-ad25-15e8-e053-a505fe0a3de9 4
Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy. results from a monoinstitutional cohort analysis of long-term survivors, file e3835317-94bc-15e8-e053-a505fe0a3de9 3
null, file e3835328-d391-15e8-e053-a505fe0a3de9 3
Chest wall infiltration is a critical prognostic factor in breast implant-associated anaplastic large-cell lymphoma affected patients, file e383532b-d561-15e8-e053-a505fe0a3de9 3
Prognostic impact and risk factors of infections in patients with chronic lymphocytic leukemia treated with ibrutinib, file e383532c-6218-15e8-e053-a505fe0a3de9 3
Single centre experience on Acquired Haemophilia A patients: Diagnosis, clinical management and analysis of factors predictive of response and outcome, file e383532d-0575-15e8-e053-a505fe0a3de9 3
Reduced Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-KP) colonization in a hematological-emergency setting during the coronavirus disease 2019 (COVID-19) pandemic, file 5dd99ce4-b9f4-4cb4-bf83-8cd5517f1ee6 2
Multiparametric Flow Cytometry in Newly Diagnosed Multiple Myeloma Patients: An Italian Monocentric Experience, file 77fdd332-1ffa-451a-944d-03f9040c0ab0 2
Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): Final results of a multicentre, open-label, randomised, controlled, phase 3 study, file e3835318-7820-15e8-e053-a505fe0a3de9 2
Final results of the IELSG-19 randomized trial of mucosa-associated lymphoid tissue lymphoma: Improved event-free and progression-free survival with rituximab plus chlorambucil versus either chlorambucil or rituximab monotherapy, file e3835318-c980-15e8-e053-a505fe0a3de9 2
Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma, file e383531a-d495-15e8-e053-a505fe0a3de9 2
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death, file e3835321-9f42-15e8-e053-a505fe0a3de9 2
Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study, file 0176a3de-e0f5-4d6a-b5db-1a35177cf1bc 1
Neoplastic bone marrow invasion:rapid exclusion of hematological disease by flow cytometric routine panels, file 40ffc73c-69de-40a7-ae83-b6228b8dd3aa 1
Case Report: Infectious prophylaxis in hematological malignancies, file 5421b9b3-d1ac-442f-8877-a46caefa38e2 1
Editorial: HBV and lymphoma, file 6ae3d2fc-d20c-4087-bf2b-a2ebcf26b180 1
Impact of Anti-Sars-Cov-2 Monoclonal Antibodies in the Management of Patients with Lymphoma and COVID19: A Retrospective Study, file 875a0f21-092e-4a8f-843a-6bf670251e4c 1
Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study, file b1d8a0cd-7428-4238-a778-a64aa7a69f4b 1
Effectiveness of Fludarabine, Idarubicin and Cyclophosphamide (FLUIC) Combination Regimen for Young Patients with Untreated Non-Follicular Low-Grade Non-Hodgkin's Lymphoma., file e3835311-8e83-15e8-e053-a505fe0a3de9 1
Localized stage I-IE aggressive non-Hodgkin's lymphoma (NHL): Results of prospective study with multimodality therapeutic approach, file e3835311-9c40-15e8-e053-a505fe0a3de9 1
[18F]Fluorodeoxyglucose Positron Emission Tomography Predicts Survival After Chemoimmunotherapy for Primary Mediastinal Large B-Cell Lymphoma: Results of the International Extranodal Lymphoma Study Group IELSG-26 Study., file e3835312-6bcd-15e8-e053-a505fe0a3de9 1
Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma, file e3835318-05b6-15e8-e053-a505fe0a3de9 1
A MALT lymphoma prognostic index, file e3835318-1a16-15e8-e053-a505fe0a3de9 1
Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma, file e3835318-75a3-15e8-e053-a505fe0a3de9 1
Prognostic models for primary mediastinal (thymic) B-cell lymphoma derived from 18-FDG PET/CT quantitative parameters in the International Extranodal Lymphoma Study Group (IELSG) 26 study, file e3835318-7745-15e8-e053-a505fe0a3de9 1
Nodal aggressive non Hodgkin’s lymphoma in the adult., file e3835318-788c-15e8-e053-a505fe0a3de9 1
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41), file e3835318-7a49-15e8-e053-a505fe0a3de9 1
Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma, file e3835318-7e1f-15e8-e053-a505fe0a3de9 1
How to identify patients at risk of developing lymphomatous meningitis [Come identificare i pazienti a rischio di sviluppare meningite linfomatosa], file e3835318-8185-15e8-e053-a505fe0a3de9 1
Lung cancer after treatment for non-Hodgkin lymphoma., file e3835318-83e9-15e8-e053-a505fe0a3de9 1
Training improves the interobserver agreement of the expert positron emission tomography review panel in primary mediastinal B-cell lymphoma: Interim analysis in the ongoing International Extranodal Lymphoma Study Group-37 study, file e3835318-b3dd-15e8-e053-a505fe0a3de9 1
Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL., file e3835321-bb95-15e8-e053-a505fe0a3de9 1
Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma, file e3835323-0a00-15e8-e053-a505fe0a3de9 1
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma, file e3835328-4e6d-15e8-e053-a505fe0a3de9 1
Totale 6.284
Categoria #
all - tutte 9.007
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.007


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019236 0 0 0 0 0 0 0 0 31 57 83 65
2019/2020901 56 45 42 49 90 94 89 93 103 90 77 73
2020/20211.344 79 80 96 74 131 139 103 145 170 112 109 106
2021/20221.549 140 114 102 259 208 64 80 112 99 72 190 109
2022/20231.199 54 64 166 173 90 130 84 141 93 65 86 53
2023/20241.018 78 65 109 67 126 104 91 362 16 0 0 0
Totale 6.284